Dwain Morris-Irvin - Mar 14, 2022 Form 4 Insider Report for NovAccess Global Inc. (XSNX)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Dwain K. Morris-Irvin
Stock symbol: XSNX
Transactions as of: Mar 14, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/14/2022, 10:09 AM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XSNX	Series B Preferred Stock, $0.01 par value per share	Other		+600			600	Mar 14, 2022	By Irvin Consulting, LLC	F1
holding	XSNX	Common Stock, no par value						1.8M	Mar 14, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XSNX	Series B Preferred Stock, $0.01 par value	Other		+600			600	Mar 14, 2022	Common Stock, no par value	6M	$0.00	By Irvin Consulting, LLC,	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Effective March 14, 2022, Irvin Consulting, LLC, a California limited liability company owned and controlled by to Dr. Irvin, purchased in a private transaction 600 shares of Series B preferred stock from TN3, LLC. Irving Consulting paid a total of $7,223 for the preferred shares.
F2	Each share of Series B preferred stock is currently convertible at the option of the holder into 10,000 shares of common stock and entitles the holder to cast 40,000 votes on any action presented to shareholders. The preferred stock conversion feature has no expiration date.